ArticleMolecular cancer therapeutics2026
Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer.
Valentina Cutano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleMolecular cancer therapeutics2026
Valentina Cutano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.